← Back
$XERS All transactions

Xeris Biopharma Holdings, Inc.

▲ BUY
4 / 10

Conviction

$ Value

$109K

Shares

25,000

Price

$4

Filed

Jun 16

Why this score? (4/10)
  • Open market buy (+3)
  • Not a 10b5-1 plan (+1)

Insider

Name

McCulloch Kevin

Title

See Remarks

CIK

0002031695

Roles

Officer

Transaction Details

Transaction Date

2025-06-13

Code

P

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

1,708,585

Footnotes

The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.3750 to $4.380, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range. | The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.

Filing Info

Accession No.

0001867096-25-000118

Form Type

4

Issuer CIK

0001867096

McCulloch Kevin's History

Date Ticker Type Value
2026-01-31 XERS F $504K
2026-01-31 XERS F $223K
2026-01-31 XERS F $201K
2026-01-30 XERS A $0
2026-01-30 XERS A $0
2026-01-08 XERS $120K
2025-10-02 XERS F $6K
2025-09-11 XERS J $0
2025-08-01 XERS F $79K
2025-06-13 XERS $109K

Other Insiders at XERS (90d)

Insider Bought Sold Last
Shannon John Patrick Jr
See Remarks
2026-01-31
Hecht Beth
See Remarks
$224K 2026-04-01
Pieper Steven
See Remarks
2026-01-31
Brady James Aloysius $60K 2026-03-30
McCulloch Kevin
See Remarks
2026-01-31
Nguyen Anh Tu
See Remarks
2026-01-30